There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Articles

Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.

Impurity Testing

Corning will become the exclusive supplier of CytoSMART's new cell counter device that simplifies mammalian cell counting.

Corning and CytoSMART Partner on Cell Counting Device

Amber Lowry is an associate editor at UBM plc.

Steve Hayward, product marketing manager at BIOVIA, Dassault Systèmes, discusses the importance of both technology and people in the modern laboratory.

Navigating Data Integrity in the Modern Lab

This article explores lab data integrity violation trends, as well as a sampling of the latest technologies that can help avoid them.

Maintaining Lab Data Integrity

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Regulations and industry guidelines focus on ensuring excipient safety by specifying risk assessments and shared responsibility.

Managing Risk in a Complex Excipient Supply Chain

Sade Mokuolu, PhD, is group product compliance manager, Watson-Marlow Fluid Technology Group. 

Proposed guidance documents assist drug manufacturers in qualifying single-use systems for commercial drug production.

New Standards Define Single-Use Materials Qualification

Cambrex invests in development and laboratory facilities and adds staff.

Cambrex Expands API Development at Iowa Facility

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics. 

Bigger is Better in Samsung's Approach to Biomanufacturing

Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.

Outsourcing Analytical Services in Early Drug Development

Agnes Shanley is senior editor of Pharmaceutical Technology.

Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes